REFERENCES
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science, 2001.
- Kazazian HHJr.. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol. 1990;27(3):209–228.
- Olivieri NF. The β-Thalassemias. N Engl J Med. 1999;341(2):99–109.
- Modell B, Petrou M, Ward RH, Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain. Lancet. 1984;2(8416):1383–1386.
- Zeng YT, Huang SZ. Disorders of haemoglobin in China. J Med Genet. 1987;24(10):578–583.
- Xu XM, Zhou YQ, Luo GX, The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Li Z, Li F, Li M, Guo R, Zhang W. The prevalence and spectrum of thalassemia in Shenzhen, Guangdong Province, People's Republic of China. Hemoglobin. 2006;30(1):9–14.
- Pan HF, Long GF, Li Q, Current status of thalassemia in minority populations in Guangxi, China. Clin Genet. 2007;71(5):419–426.
- Ma SK, Ha SY, Chan AY, Chan GC, Lau YL, Chan LC. Two novel β-thalassemia alleles in the Chinese: the IVS-II-2 (–T) and nucleotide +8 (C - >T) β-globin gene mutations. Hemoglobin. 2000;24(4):327–332.
- Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222.